Live Breaking News & Updates on Michael Tardugno|Page 1

Stay updated with breaking news from Michael tardugno. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Imunon, Inc.: IMUNON Announces Site Activation for IMNN-101 Phase 1 Vaccine Study

Imunon, Inc.: IMUNON Announces Site Activation for IMNN-101 Phase 1 Vaccine Study
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Kim Sutton Golodetz , Michael Tardugno , Products Advisory Committee , Clinical Trial Network , Exchange Commission , World Vaccine Congress Washington , Jeffreyw Church , Globe Newswire Imunon Inc , Dm Clinical Research , Vaccine Industry Excellence , Executive Chairman , Related Biological Products Advisory Committee , Private Securities Litigation Reform Act , Chance Des ,

IMUNON'S IND Application Cleared To Begin Human Testing Of IMNN-101

IMUNON'S IND Application Cleared To Begin Human Testing Of IMNN-101
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

Michael Tardugno , Nasdaq Company , Drug Administration , Products Advisory Committee , Globe Newswire Imunon Inc , Investigational New Drug , Related Biological Products Advisory Committee ,

Imunon, Inc.: IMUNON's IND Application Cleared to Begin Human Testing of IMNN-101

Imunon, Inc.: IMUNON's IND Application Cleared to Begin Human Testing of IMNN-101
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Dennis Riedl , Kim Sutton Golodetz , Michael Tardugno , Jeffreyw Church , Drug Administration , Exchange Commission , Products Advisory Committee , Investigational New Drug , Related Biological Products Advisory Committee , Private Securities Litigation Reform Act , Aktien Sie ,

Imunon, Inc. (NASDAQ:IMNN) Q4 2023 Earnings Call Transcript

Imunon, Inc. (NASDAQ:IMNN) Q4 2023 Earnings Call Transcript March 28, 2024 Imunon, Inc. beats earnings expectations. Reported EPS is $-0.52, expectations were $-0.59. Imunon, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. My name is Dave, and […] ....

New Jersey , United States , Michael Tardugno , Hudson Technology Finance Corporation , Jeffrey Church , Silicon Valley Bank , Kursheed Anwer , Silicon Valley , Hudson Technology Finance , Obese Countries ,